Search Results - "Riesen, W"

Short-term effects of atorvastatin on C-reactive protein by Riesen, W.F., Engler, H., Risch, M., Korte, W., Noseda, G.

“…Aim To study the short-term effect of atorvastatin on C-reactive protein (CRP) in patients with or at risk for coronary heart disease. Methods and Results One…”
Get full text

Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country by Conen, D, Wietlisbach, V, Bovet, P, Shamlaye, C, Riesen, W, Paccaud, F, Burnier, M

“…The prevalence of hyperuricemia has rarely been investigated in developing countries. The purpose of the present study was to investigate the prevalence of…”
Get full text

Dark chocolate improves endothelial and platelet function by Hermann, F, Spieker, L E, Ruschitzka, F, Sudano, I, Hermann, M, Binggeli, C, Lüscher, T F, Riesen, W, Noll, G, Corti, R

Get full text

Vitamin D levels in Swiss breast cancer survivors by Baumann, M, Dani, S, Dietrich, D, Hochstrasser, A, Mark, M.T, Riesen, W, Ruhstaller, T, Templeton, A.J, Thürlimann, B

Get full text

Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates by Joerger, M., Templeton, A., Köberle, D., Engler, H., Riesen, W. F., Thürlimann, B.

“…Background There is an urgent need for individualized treatment of malignant bone disease (MBD), as the clinical benefit from bone-targeted therapies is…”
Get full text

Hypertriglyceridemia as a possible risk factor for prostate cancer by Wuermli, L, Joerger, M, Henz, S, Schmid, H-P, Riesen, W F, Thomas, G, Krek, W, Cerny, T, Gillessen, S

“…We retrospectively studied anthropometric and laboratory parameters (including serum triglycerides, cholesterol), as well as comedication in 504 patients…”
Get full text

Bevacizumab-associated hyperlipoproteinemia type IIb in a patient with advanced invasive-ductal breast cancer by Joerger, M, Riesen, WF, Thürlimann, B

“…Aim: We report a case of bevacizumab-associated hyperlipoproteinemia in a patient with advanced breast cancer. Case summary: A 57-year-old woman with advanced…”
Get full text

N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis by Wolber, T., Maeder, M., Rickli, H., Riesen, W., Binggeli, C., Duru, F., Ammann, P.

“…Background  The level of the inactive N‐terminal fragment of pro‐brain (B‐type) natriuretic peptide (NT‐proBNP) is a prognostic marker in patients with acute…”
Get full text

Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media by Rickli, H, Benou, K, Ammann, P, Fehr, Th, Brunner-La Rocca, H P, Petridis, H, Riesen, W, Wüthrich, R P

“…The delayed increase of creatinine after radiocontrast application is a potential reason for overlooking radiocontrast nephrotoxicity. Cystatin C may be more…”
Get more information

Combining bone resorption markers and heel quantitative ultrasound to discriminate between fracture cases and controls by Nanchen, D, Cornuz, J, Ruffieux, C, Riesen, W, Burckhardt, P, Krieg, M. A

“…Summary This nested case-control analysis of a Swiss ambulatory cohort of elderly women assessed the discriminatory power of urinary markers of bone resorption…”
Get full text

Role of RAS Inhibition in the Regulation of Cu/Zn-SOD in the Cardiac and Peripheral Arterial Beds in Humans by Kuster, G M, Nietlispach, F, Kiowski, W, Schindler, R, Bernheim, A, Schuetz, P, Mueller, B, Morgenthaler, N G, Rüter, F, Riesen, W, Rickli, H, Brunner‐La Rocca, H P

“…Inhibition of the renin–angiotensin system (RAS) improves hemodynamics and may ameliorate oxidative stress in heart failure (HF). Through activation of…”
Get full text

Comparison of different transvaginal ovum pick-up protocols to optimise oocyte retrieval and embryo production over a 10-week period in cows by Chaubal, S.A., Molina, J.A., Ohlrichs, C.L., Ferre, L.B., Faber, D.C., Bols, P.E.J., Riesen, J.W., Tian, X., Yang, X.

“…The objective was to develop a simple and effective ovum pick-up (OPU) protocol for cows, optimised for oocyte harvest and subsequent in vitro embryo…”
Get full text

Effect of thyroid function on concentrations of lipoprotein(a) by Engler, H, Riesen, W F

“…The effect of thyroid hormones on concentrations of lipoprotein(a) [Lp(a)] was analyzed in 60 patients with active thyroid dysfunction (hyperthyroidism 30…”
Get more information

Alterations of lipolytic enzymes and high-density lipoprotein subfractions induced by physical activity in type 2 diabetes mellitus by Lehmann, R., Engler, H., Honegger, R., Riesen, W., Spinas, G. A.

“…Objective This study investigates the effects of regular moderate physical activity on lipolytic enzymes and plasma lipid concentration, particularly…”
Get full text

Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression by HOCK, C, HEESE, K, MÜLLER-SPAHN, F, HUBER, P, RIESEN, W, NITSCH, R. M, OTTEN, U

“…Neurotrophin 3 (NT-3) is a member of the neurotrophin gene family which supports the survival of specific neurons. NT-3 was shown to prevent the death of adult…”
Get full text

Increased CSF levels of nerve growth factor in patients with Alzheimer's disease by HOCK, C, HEESE, K, MÜLLER-SPAHN, F, HUBER, P, RIESEN, W, NITSCH, R. M, OTTEN, U

“…The authors quantitated CSF levels of nerve growth factor (NGF) in patients with AD, nondemented control subjects (CTR), and age-matched patients with major…”
Get full text

Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus by ZENOBI, P. D, JAEGGI-GROISMAN, S. E, RIESEN, W. F, RØDER, M. E, FROESCH, E. R

“…Hyperglycemia, hyperinsulinemia, and insulin resistance cause vascular disease in type 2 diabetes mellitus. Dietary treatment alone often fails and oral drugs…”
Get full text

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) by Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., Graham, I. M., Halliday, A., Landmesser, U., Mihaylova, B., Pedersen, T. R., Riccardi, G., Richter, D. J., Sabatine, M. S., Taskinen, M. R., Tokgozoglu, L., Wiklund, Olov, Mueller, C., Drexel, H., Aboyans, V., Corsini, A., Doehner, W., Farnier, M., Gigante, B., Kayikcioglu, M., Krstacic, G., Lambrinou, E., Lewis, B. S., Masip, J., Moulin, P., Petersen, S., Petronio, A. S., Piepoli, M. F., Pinto, X., Raber, L., Ray, K. K., Reiner, Z., Riesen, W. F., Roffi, M., Schmid, J. P., Shlyakhto, E., Simpson, I. A., Stroes, E., Sudano, I., Tselepis, A. D., Viigimaa, M., Vindis, C., Vonbank, A., Vrablik, M., Vrsalovic, M., Gomez, J. L. Z., Collet, J. P.

Get full text

Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study by Engler, Hanna, Oettli, René E, Riesen, Walter F

“…Hyperthyroidism is associated with reduced bone mineral density. Conflicting data exist regarding the effects of thyroxine therapy on bone metabolism. The aim…”
Get full text

Comparison of Bezafibrate and Simvastatin in the Treatment of Dyslipidaemia in Patients with NIDDM by Jeck, T., Riesen, W.F., Keller, U.

“…Fibrates and HMG CoA reductase inhibitors are commonly used in the treatment of diabetic dyslipidaemia. However, these two groups of drugs have not been…”
Get full text